The role of an androgen receptor polymorphism in the clinical outcome of patients with metastatic prostate cancer

Urologia Internationalis

Volumn 68, Issue 1, 2002, Pages 16-23

  Cude, Kelly J ^a   Montgomery, Jeffrey S ^a   Price, Douglas K ^a   Dixon, Shannon C ^a   Kincaid, Randall L ^a   Kovacs, Karl F ^a   Venzon, David J ^a   Liewehr, David J ^a   Johnson, Margaret E ^a   Reed, Eddie ^a   Figg, William D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Androgen receptor; CAG trinucleotide repeat; Prostate cancer

Indexed keywords

ANDROGEN RECEPTOR; DNA;

ADULT; AGED; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA ISOLATION; DNA SEQUENCE; EXON; GENE AMPLIFICATION; HISTOLOGY; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN FUNCTION; SURVIVAL TIME; TRANSACTIVATION; TRINUCLEOTIDE REPEAT;

ADENOCARCINOMA; ADULT; AGED; BASE SEQUENCE; DNA, NEOPLASM; GENETIC MARKERS; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROGNOSIS; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; SURVIVAL RATE;

EID: 18244366664     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000048412     Document Type: Article

References (25)

1. Cancer statistics, 1999
2. Prostate cancer and the androgen receptor
3. Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: Possible pathogenetic relevance for the (CAG)-n-expanded neuronopathies
4. 24-18) in the androgen receptor gene in human prostate cancer
5. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function
6. Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility
7. Transcriptional activation modulated by homopolymeric glutamine and proline stretches
8. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer
9. Androgen receptor gene mutations in X-linked spinal and bullar muscular atrophy
10. Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy
11. Androgen receptor gene CAG repeat length varies in a race-specific fashion in men without prostate cancer
12. The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia
13. CAG repeat within the androgen receptor and incidence of surgery for benign prostatic hyperplasia in US Physicians
14. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer
15. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor
16. Polymorphic repeats in the androgen receptor gene: Molecular markers of prostate cancer risk
17. CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk
18. Androgen receptor polymorphisms: Association with prostate cancer risk, relapse, and overall survival
19. Androgen receptor CAG repeat lengths in prostate cancer: Correlation with age of onset
20. Antitumor activity of suramin in hormone-refractory prostate cancer controlling for hydrocortisone treatment and flutamide withdrawal as potentially confounding variable
21. Phase II study of suramin plus aminoglutethimide in two cohorts of patients with androgen-independent prostate cancer: Simultaneous antiandrogen withdrawal and prior antiandrogen withdrawal
22. A phase I/II study of continuous infusion suramin in patients with hormone-refractory prostate cancer: Toxicity and response
23. Phase II trial of suramin, leuprolide, and flutamide in previously untreated metastatic prostate cancer
24. Methods for extracting and amplifying genomic DNA isolated from frozen serum
25. Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer